Novavax bosses cash out profits with vaccine trials under way

Photo: EPA Stanley Erck

Some top executives at US pharmaceutical company Novavax have started selling some of their stocks in a bid to capitalize on positive outlook amid on-going trials of the firm’s Covid-19 vaccine, Reuters reported.

Novavax chief executive Stanley Erck and three of his top managers have sold some $46 million worth of company stock since the start of last year. According to a Reuters review of securities filings the sales were focused on profit taking from a 3,000% rally in Novavax shares fueled by investors betting on the success of the shot under development.

Erck cashed out $8,7 million over the course of 2020. The stock sale amounts to more than 20% of his vested stake in Novavax, or less than 10% if stock.

There is no certainty yet that Novavax, which has yet to bring a vaccine to market, will be successful. The company has become a key contender in a global race to develop vaccines against Covid-19 thanks to $1,6 billion in taxpayer funding it received under the U.S. government’s “Operation Warp Speed” programme.

The company was worth only $250 million until about a year ago, when news of its experimental vaccine and its participation in Operation Warp Speed drove its valuation up to as much as $11 billion.

Novavax has announced that it had begun a late-stage trial of its Covid-19 vaccine in the United States, after delaying it twice due to issues in scaling up its manufacturing. It expects to see the results from another late-stage trial, in the United Kingdom, sometime in the first quarter of 2021.

Similar articles

  • Daimler buys 33% stake in battery cell producer

    Daimler buys 33% stake in battery cell producer

    German Daimler announced it would acquire a 33% stake in battery cells Automotive Cells Company (ACC). The maker of Mercedes Benz will partner in the joint venture alongside with the project's original founders Stellantis and TotalEnergies, Reuters reported. The purpose of the partnership is to develop cells and battery modules and "help ensure that Europe remains at the heart of the auto industry even in an electric era", Daimler Chief Executive Ola Kaellenius said in a statement.

  • Boeing sees China jet demand spike to $1.47tn over next 20 years

    Boeing sees China jet demand spike to $1.47tn over next 20 years

    The airplane builder Boeing increased its previous forecast for expected China aircraft demand for the next 20 years, noting the fast economic recovery from pandemic and expected raise in budget traveling worldwide. Th Chinese airlines will need at lesat 8,700 new airplanes through 2040, 1.2% more than previous prediction of 8,600 planes made last year. Those would be worth $1.47 trillion based on list prices, the US planemaker said in a statement.

  • Airbnb looses 80% of its business due to Covid-19

    Airbnb looses 80% of its business due to Covid-19

    The way people used to travel has been dramatically changed forever by the Covid-19 pandemic, the boss of lodging platform Airbnb said. Brian Chesky told the BBC the lines between business and leisure travel are waning because of remote working patterns. And he noted that people are opting for longer periods with family and friends as they seek more "human connection".